Does human milk reduce infection rates in preterm infants
Citation: De Silva A., Jones P., & Spencer S. Does human milk reduce infection rates in preterm infants? A systematic review. Archives of Disease in Childhood Fetal and Neonatal Edition, 2004;89(6):F509–F513.
The advantage of human milk (HM) in preventing infection in preterm, very low birth weight (VLBW) infants is not proven by the existing studies. Recommendations have been made regarding the methodology required for further study of this important topic.
It has been believed that HM provides advantageous effects for infants, including providing a degree of protection from infection. Given the importance of adequate nutrition for infants, as well as the difficulties associated with providing HM to all infants, it is key that the outcomes of HM feeding practices are clearly known. This review aimed to assess all publications concerned with human milk feeding and infection VLBW preterm infants. Nine studies were included in the review, assessed according to specific, predefined criteria. Poor quality and other methodological issues were noted. Results showed that statistically, most cohort studies showed bias in favour of HM groups in terms of higher maternal socio-demographic variables. HM had a protective effect in reducing infection when compared with formula milk in the conclusions from all nine studies. The results are not considered concrete, given the methodological instability and were interpreted with caution.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence the prevention and treatment of malnutrition but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about prevention or treatment of malnutirition on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.